Weekly pulmonary delivery of beta-glucan-chitosan-poly(lactic co-glycolic) acid (beta-C-P) nanoparticles with daily standard oral therapy achieves control of Mycobacterium tuberculosis in BALB/c mice. (journals.asm.org)

Authors: Kutscher HL … Reynolds JL Journal: Antimicrobial Agents and Chemotherapy Published: 2026-06-03 DOI: https://doi.org/10.1128/aac.00281-26